other
confidence high
sentiment neutral
materiality 0.20
Prime Medicine amends charter and bylaws upon IPO closing
Prime Medicine, Inc.
- Third amended charter authorizes 775M shares common and 10M shares undesignated preferred.
- Bylaws eliminate stockholder written consent and restrict special meetings.
- Advance notice procedure adopted for stockholder proposals and director nominations.
- Changes became effective immediately prior to IPO closing on October 19, 2022.